Upgrade to SI Premium - Free Trial

Olema Pharmaceuticals (OLMA)

11.49 -0.10 (0.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: BVF I GP LLC June 23, 2026 5:52 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Harmon Cyrus June 23, 2026 5:30 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: BUTITTA CYNTHIA M June 23, 2026 5:29 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Garland J. Scott June 23, 2026 5:28 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Hrustanovic Gorjan June 23, 2026 5:27 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: CLARK IAN T June 23, 2026 5:27 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Larson Yi June 23, 2026 5:26 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Horning Sandra June 23, 2026 5:25 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Raman Prakash June 23, 2026 5:24 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: RAPPAPORT ANDREW June 23, 2026 5:22 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Graham G. Walmsley June 23, 2026 5:21 PM - SEC Filing Form 8-K Olema Pharmaceuticals, For: Jun 17 June 23, 2026 4:20 PM - SEC Filing Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode June 1, 2026 9:05 AM - StreetInsider Form 8-K Olema Pharmaceuticals, For: May 26 May 26, 2026 7:05 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA) May 22, 2026 6:54 AM - StreetInsider Form 8-K Olema Pharmaceuticals, For: May 21 May 21, 2026 5:06 PM - SEC Filing Olema Oncology reports early phase 1 data for cancer drug OP-3136 May 21, 2026 5:00 PM - StreetInsider Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting May 21, 2026 5:00 PM - Globe NewsWire Olema Oncology to Participate in Upcoming Investor Conferences May 19, 2026 4:30 PM - Globe NewsWire Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P. May 15, 2026 4:35 PM - SEC Filing Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC May 15, 2026 12:39 PM - SEC Filing Citi Adjusts Catalyst Watch Names May 13, 2026 4:09 PM - StreetInsider Olema Pharmaceuticals (OLMA) PT Lowered to $35 at Guggenheim May 13, 2026 6:38 AM - StreetInsider Form 10-Q Olema Pharmaceuticals, For: Mar 31 May 12, 2026 7:11 AM - SEC Filing Olema Pharmaceuticals, Inc. (OLMA) Tops Q1 EPS by 1c May 12, 2026 7:09 AM - StreetInsider Form 8-K Olema Pharmaceuticals, For: May 12 May 12, 2026 7:05 AM - SEC Filing Olema Oncology Reports First Quarter 2026 Financial and Operating Results May 12, 2026 7:00 AM - Globe NewsWire Form 8-K Olema Pharmaceuticals, For: Apr 27 May 1, 2026 5:28 PM - SEC Filing Form 4 Olema Pharmaceuticals, For: Apr 28 Filed by: Raman Prakash April 29, 2026 7:54 PM - SEC Filing Form 3 Olema Pharmaceuticals, For: Apr 28 Filed by: Raman Prakash April 29, 2026 4:40 PM - SEC Filing Form ARS Olema Pharmaceuticals, For: Dec 31 April 29, 2026 4:38 PM - SEC Filing Form DEFA14A Olema Pharmaceuticals, April 29, 2026 4:37 PM - SEC Filing Form DEF 14A Olema Pharmaceuticals, For: Apr 29 April 29, 2026 4:36 PM - SEC Filing Form 8-K Olema Pharmaceuticals, For: Apr 27 April 29, 2026 4:35 PM - SEC Filing Olema Oncology appoints Prakash Raman to board of directors April 29, 2026 4:01 PM - StreetInsider Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors April 29, 2026 4:01 PM - Globe NewsWire Full Article List